Last edition
News about "Andrew Newland"
ANGLE Forms Strategic Collaboration with Myriad Genetics
ANGLE plc has entered into a collaboration with Myriad Genetics to evaluate circulating tumour cell DNA using ANGLE’s Parsortix system alongside Myriad’s tissue-based assays, aiming to advance precision oncology.
Andrew Newland | 22/08/2025 | By Mrinmoy Dey | 142
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members